Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity

B Zingales - Acta tropica, 2018 - Elsevier
The genetic diversity of Trypanosoma cruzi, the protozoan agent of Chagas disease, is
widely recognized. At present, T. cruzi is partitioned into seven discrete typing units (DTUs) …

Pathogen diversity, immunity, and the fate of infections: lessons learned from Trypanosoma cruzi human–host interactions

LMD Magalhães, KJ Gollob, B Zingales… - The Lancet …, 2022 - thelancet.com
The complexity of host–pathogen interactions often leads to distinct clinical outcomes upon
infection with different pathogen strains. In this Review, we explore the interactions between …

Molecular diagnosis of Trypanosoma cruzi

AG Schijman - Acta tropica, 2018 - Elsevier
Chagas disease, caused by the kinetoplastid protozoan Trypanosoma cruzi, affects millions
of people, most of them neglected populations. The different phases of the disease, the …

Prevalence of Chagas disease in Colombia: A systematic review and meta-analysis

MJ Olivera, JA Fory, JF Porras, G Buitrago - PloS one, 2019 - journals.plos.org
Background Despite the adoption of campaigns to interrupt the main vector and to detect
Trypanosoma cruzi in blood banks, millions of people are still chronically infected; however …

Understanding the oral transmission of Trypanosoma cruzi as a veterinary and medical foodborne zoonosis

N Velásquez-Ortiz, JD Ramírez - Research in veterinary science, 2020 - Elsevier
Chagas disease is a neglected tropical disease transmitted by the protozoan Trypanosoma
cruzi that lately has been highlighted because several outbreaks attributed to oral …

Efficacy and safety of nifurtimox in pediatric patients with Chagas disease: results at 4-year follow-up in a prospective, historically controlled study (CHICO SECURE)

J Altcheh, V Sierra, T Ramirez… - Antimicrobial Agents …, 2023 - Am Soc Microbiol
Nifurtimox is recommended for the treatment of Chagas disease; however, long-term follow-
up data are scarce. This prolonged follow-up phase of the prospective, historically …

Parasitological, serological and molecular diagnosis of acute and chronic Chagas disease: from field to laboratory

AG Schijman, J Alonso-Padilla, SA Longhi… - Memórias do instituto …, 2022 - SciELO Brasil
There is no consensus on the diagnostic algorithms for many scenarios of Trypanosoma
cruzi infection, which hinders the establishment of governmental guidelines in endemic and …

Trypanosoma cruzi loop-mediated isothermal amplification (Trypanosoma cruzi Loopamp) kit for detection of congenital, acute and Chagas disease reactivation

SA Besuschio, A Picado… - PLoS Neglected …, 2020 - journals.plos.org
A Trypanosoma cruzi Loopamp kit was recently developed as a ready-to-use diagnostic
method requiring minimal laboratory facilities. We evaluated its diagnostic accuracy for …

Untangling the transmission dynamics of primary and secondary vectors of Trypanosoma cruzi in Colombia: parasite infection, feeding sources and discrete typing …

C Hernández, C Salazar, H Brochero, A Teherán… - Parasites & …, 2016 - Springer
Background Trypanosoma cruzi is the causative agent of Chagas disease. Due to its genetic
diversity has been classified into six Discrete Typing Units (DTUs) in association with …

Trypanosoma cruzi Parasite Burdens of Several Triatomine Species in Colombia

N Velásquez-Ortiz, C Hernández… - Tropical medicine and …, 2022 - mdpi.com
Trypanosoma cruzi, the causal agent of Chagas disease, is mainly transmitted by insects of
the Triatominae subfamily. In Colombia, there are 26 triatomine species, and 16 of them are …